Have a personal or library account? Click to login
Pharmacoresistant epilepsy associated with mutations in the KCNB1 and RELN genes. A case report Cover

Pharmacoresistant epilepsy associated with mutations in the KCNB1 and RELN genes. A case report

Journal of Epileptology
Volume 28 (2020): Issue 1 (December 2020)
By: Adamantios Katerelos,  Nikolaos Zagkos,  Dimitra Alexopoulou,  Stella Mouskou,  Anastasia Korona and  Emmanouil Manolakos  
Open Access
|Nov 2020

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.21307/joepi-2020-006 | Journal eISSN: 2299-9728 | Journal ISSN: 2300-0147
Journal RSS Feed
Language: English
Page range: 73 - 77
Submitted on: Jul 31, 2020
Accepted on: Oct 15, 2020
Published on: Nov 25, 2020
Published by: The Foundation of Epileptology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
pharmacoresistant epilepsy,
KCNB1 gene,
RELN gene,
delayed speech
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Neurology,
Pharmacology, toxicology,
Pharmacy,
Clinical pharmacy

© 2020 Adamantios Katerelos, Nikolaos Zagkos, Dimitra Alexopoulou, Stella Mouskou, Anastasia Korona, Emmanouil Manolakos, published by The Foundation of Epileptology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 28 (2020): Issue 1 (December 2020)Next article